BWAY
Brainsway
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: BWAY
- PE Ratio
As of Jun 3, 2026, the Brainsway stock's price-to-earnings ratio is 61.04. This results from the current EPS of $0.23 and stock price of $14.04. The PE ratio has increased by 26% from the past four quarters average of 48.4.
BWAY PE ratio history
The PE ratio of Brainsway has averaged 88.04 over the last two years. The current P/E ratio of 61.04 is 31% lower than the historical average. In the past two years, BWAY's PE ratio peaked in the Jun 2024 quarter at 303.5, when the stock price was $3.04 and the EPS was $0.01. The lowest point was in the Mar 2025 quarter, when it reached 39.46 with a price of $4.74 and an EPS of $0.12.
Brainsway PE ratio by year
Maximum annual decrease: -9.24% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 47.55 | -9.24% | $9.51 | $0.2 |
| 2024 | 52.39 | N/A | $4.72 | $0.09 |
| 2023 | N/A | N/A | $3.24 | -$0.13 |
| 2022 | N/A | N/A | $1.24 | -$0.4 |
| 2021 | N/A | N/A | $3.85 | -$0.21 |
| 2020 | N/A | N/A | $3.77 | -$0.24 |
| 2019 | N/A | N/A | $4.88 | -$0.5 |
| 2018 | N/A | N/A | N/A | -$0.39 |
| 2017 | N/A | N/A | N/A | -$0.48 |
Brainsway PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 57.78 | 21.51% | $13.29 | $0.23 |
| Dec 2025 | 47.55 | 7.29% | $9.51 | $0.2 |
| Sep 2025 | 44.32 | 1.12% | $7.54 | $0.17 |
| Jun 2025 | 43.83 | 11.07% | $6.58 | $0.15 |
| Mar 2025 | 39.46 | -24.68% | $4.74 | $0.12 |
| Dec 2024 | 52.39 | -54.64% | $4.72 | $0.09 |
| Sep 2024 | 115.5 | -61.94% | $4.62 | $0.04 |
| Jun 2024 | 303.5 | N/A | $3.04 | $0.01 |
| Mar 2024 | N/A | N/A | $2.65 | -$0.06 |
| Dec 2023 | N/A | N/A | $3.24 | -$0.13 |
| Sep 2023 | N/A | N/A | $2.02 | -$0.24 |
| Jun 2023 | N/A | N/A | $1.14 | -$0.38 |
| Mar 2023 | N/A | N/A | $0.88 | -$0.4 |
| Dec 2022 | N/A | N/A | $1.24 | -$0.4 |
| Sep 2022 | N/A | N/A | $1.81 | -$0.31 |
BWAY Price vs fair value
BWAY average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
BWAY's current P/E ratio is lower than the 3 and 5-year averages.
PE comparison
With a P/E of 61.04, BWAY stands above the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 23.02, Brainsway's P/E is 165% higher.
BWAY PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| BWAY Brainsway Ltd | 62.35 | $561.64M |
| OBIO Orchestra BioMed Holdings Inc | N/A | $238.92M |
Frequently asked questions
What is Brainsway's PE ratio?
BWAY's price to earnings ratio is 61.04 as of Jun 3, 2026.
What is the 3-year average PE ratio for Brainsway (BWAY)?
Over the last 3 years, the average price to earnings ratio for BWAY stock is 88.04.
What is the 5-year average PE ratio for Brainsway (BWAY)?
Over the last 5 years, the average price to earnings ratio for BWAY stock is 88.04.
What is the highest PE ratio for BWAY?
In the last two years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 303.5.
How does the current PE ratio for BWAY compare to its historical average?
BWAY's price to earnings ratio is currently 31% below its 2-year historical average.
How is BWAY's PE ratio calculated (Brainsway PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 3, 2026), Brainsway's stock price is $14.04. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.23. Therefore, Brainsway's PE ratio for today is 61.04. PE RATIO(61.04) = STOCK PRICE($14.04) / TTM EPS($0.23)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.